Results 81 to 90 of about 302,595 (156)

Mpox in endemic regions in Nigeria: awareness, knowledge, and willingness to accept the mpox vaccine

open access: yesPan African Medical Journal
Nigeria ranks second in Africa for the highest number of mpox cases. This study aimed to evaluate the knowledge and awareness of mpox among Nigerians living in endemic regions and their willingness to accept the mpox vaccine when available.we conducted a cross-sectional study using a multi-stage sampling technique.
Olufadewa, Isaac Iyinoluwa   +12 more
openaire   +3 more sources

A Decade of the Global STI Vaccine Roadmap: Progress, Gaps and Challenges

open access: yes
Journal of the International AIDS Society, Volume 29, Issue S2, July 2026.
Remco P. H. Peters   +4 more
wiley   +1 more source

Survey of mpox knowledge, attitudes, and practices among men who have sex with men and their vaccination intention based on Protection Motivation Theory [PDF]

open access: yesJournal of Men's Health
Background: The study aimed to investigate mpox-related knowledge, attitudes, and practices (KAP) among men who have sex with men (MSM), and to examine vaccination intention and its associated factors, to provide scientific evidence for future health ...
Yi Liu   +8 more
doaj   +1 more source

Patterns and Gaps in Mpox Vaccination at NYC Health + Hospitals, a Large Urban Safety Net Health System in New York City, 2022-2025

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Background: NYC Health + Hospitals (H+H) provides care to large communities experiencing social vulnerability. During the 2022 mpox outbreak, H+H implemented a large-scale, targeted mpox vaccination campaign using electronic health record (EHR) reminders
Anthony Lo Piccolo   +8 more
doaj   +1 more source

A cross-sectional study of Mpox Knowledge, Attitudes toward Mpox Vaccination and Mpox Vaccine Hesitancy Among Teachers in Kenya

open access: yes
Abstract Background: Sixteen African countries, including Kenya, reported mpox cases in July and August, prompting the Africa Centers for Disease Control to declare the outbreak a Public Health Emergency of Continental Security on 13th August 2024.
Patrick M.Mutua   +3 more
openaire   +1 more source

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

open access: yes
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source

Developing accessible and affordable tests to support mpox immunosurveillance and vaccine studies

open access: yesEmerging Microbes and Infections
Mpox is an ongoing threat to international health security requiring ongoing research. Antibody tests are needed for surveillance studies to understand clinical and sub-clinical transmission risks and respond to outbreaks.
Sian E. Faustini   +5 more
doaj   +1 more source

Mpox Vaccine Acceptance, Democratic Republic of the Congo

open access: yesEmerging Infectious Diseases
We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic of the Congo among 5,226 survey respondents. Healthcare workers and respondents in historic mpox-endemic regions had higher acceptance rates. These data highlight the need for increased community engagement and sensitization before widespread deployment of mpox vaccines.
Petrichko, Skylar   +11 more
openaire   +4 more sources

Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals

open access: yesnpj Vaccines
Mpox is a significant health concern as an infectious disease. Therefore, understanding the immune response triggered in individuals vaccinated with JYNNEOS and those diagnosed with mpox requires further investigation.
Mariella Sousa Coêlho Maciel   +7 more
doaj   +1 more source

Mpox vaccine: post-vaccine advice [v3.0]

open access: yes, 2023
Advice about MVA-BN vaccine in response to Mpox.
openaire   +1 more source

Home - About - Disclaimer - Privacy